Sanofi India Limited [SANOFI] vs Alembic [APLLTD] Detailed Stock Comparison

Sanofi India Limited

NSE
Loading...

Alembic Pharmaceuticals Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sanofi India Limited wins in 12 metrics, Alembic Pharmaceuticals Ltd. wins in 8 metrics, with 0 ties. Sanofi India Limited appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sanofi India Limited Alembic Pharmaceuticals Ltd. Better
P/E Ratio (TTM) 24.31 23.42 Alembic Pharmaceuticals Ltd.
Price-to-Book Ratio 10.59 2.77 Alembic Pharmaceuticals Ltd.
Debt-to-Equity Ratio 2.38 28.00 Sanofi India Limited
PEG Ratio -0.97 -1.77 Sanofi India Limited
EV/EBITDA 16.08 14.29 Alembic Pharmaceuticals Ltd.
Profit Margin (TTM) 17.78% 8.66% Sanofi India Limited
Operating Margin (TTM) 19.32% 11.37% Sanofi India Limited
EBITDA Margin (TTM) 19.32% 11.37% Sanofi India Limited
Return on Equity 40.59% 11.24% Sanofi India Limited
Return on Assets (TTM) 19.81% 7.51% Sanofi India Limited
Free Cash Flow (TTM) $4.13B $-4.76B Sanofi India Limited
Dividend Yield 4.60% 1.09% Sanofi India Limited
1-Year Return -49.23% -25.60% Alembic Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 4.32 2.03 Alembic Pharmaceuticals Ltd.
Enterprise Value $78.16B $161.16B Alembic Pharmaceuticals Ltd.
EV/Revenue Ratio 4.25 2.22 Alembic Pharmaceuticals Ltd.
Gross Profit Margin (TTM) 50.43% 71.81% Alembic Pharmaceuticals Ltd.
Revenue per Share (TTM) $798 $371 Sanofi India Limited
Earnings per Share (Diluted) $141.75 $32.07 Sanofi India Limited
Beta (Stock Volatility) 0.18 0.34 Sanofi India Limited

Sanofi India Limited vs Alembic Pharmaceuticals Ltd. Stock Performance Analysis

Loading Price Chart...

SANOFI
APLLTD

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sanofi India Limited3.84%2.46%0.71%-5.74%-22.80%-20.92%
Alembic Pharmaceuticals Ltd.-0.75%-1.04%-5.91%9.25%-14.68%-11.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sanofi India Limited-49.23%-54.97%-58.99%-25.65%55.45%103.00%
Alembic Pharmaceuticals Ltd.-25.60%20.70%-23.84%41.04%1,498.60%1,498.60%

Performance & Financial Health Analysis: Sanofi India Limited vs Alembic Pharmaceuticals Ltd.

MetricSANOFIAPLLTD
Market Information
Market Cap i₹79.35B₹147.63B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i46,43075,949
90 Day Avg. Volume i36,764103,405
Last Close₹3,240.70₹737.75
52 Week Range₹3,054.00 - ₹6,410.00₹635.80 - ₹1,107.90
% from 52W High-49.44%-33.41%
All-Time High₹10,524.95 (Jun 10, 2024)₹1,303.90 (Oct 07, 2024)
% from All-Time High-69.21%-43.42%
Growth Metrics
Quarterly Revenue Growth-0.19%0.11%
Quarterly Earnings Growth-0.33%-0.04%
Financial Health
Profit Margin (TTM) i0.18%0.09%
Operating Margin (TTM) i0.19%0.11%
Return on Equity (TTM) i0.41%0.11%
Debt to Equity (MRQ) i2.3828.00
Cash & Liquidity
Book Value per Share (MRQ)₹325.31₹270.70
Cash per Share (MRQ)₹114.15₹7.27
Operating Cash Flow (TTM) i₹4.38B₹-3,101,700,000
Levered Free Cash Flow (TTM) i₹3.58B₹5.83B
Dividends
Last 12-Month Dividend Yield i4.60%1.09%
Last 12-Month Dividend i₹192.00₹11.00

Valuation & Enterprise Metrics Analysis: Sanofi India Limited vs Alembic Pharmaceuticals Ltd.

MetricSANOFI (Apr 24, 2026)APLLTD (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i24.3123.42
Forward P/E i19.4317.75
PEG Ratio i-0.97-1.77
Price to Sales (TTM) i4.322.03
Price to Book (MRQ) i10.592.77
Market Capitalization
Market Capitalization i₹79.35B₹147.63B
Enterprise Value i₹78.16B₹161.16B
Enterprise Value Metrics
Enterprise to Revenue i4.252.22
Enterprise to EBITDA i16.0814.29
Risk & Other Metrics
Beta i0.180.34
Book Value per Share (MRQ) i₹325.31₹270.70

Financial Statements Comparison: Sanofi India Limited vs Alembic Pharmaceuticals Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSANOFI (2025)APLLTD (2025)
Revenue/Sales i18.23B65.40B
Cost of Goods Sold i9.06B21.37B
COGS % of Revenue i49.7%32.7%
Gross Profit i9.18B44.03B
Gross Margin i50.3%67.3%
Research & Development iN/A96.00M
Operating Income (EBIT) i4.54B7.35B
Operating Margin i24.9%11.2%
EBITDA i5.10B10.52B
EBITDA Margin i28.0%16.1%
Pre-Tax Income i4.45B7.07B
Pre-Tax Income % of Revenue i24.4%10.8%
Income Tax i1.18B1.25B
Income Tax % of Revenue i6.5%1.9%
Net Income (Profit) i3.27B5.82B
Profit Margin i17.9%8.9%

Balance Sheet & Liquidity Metrics

MetricSANOFI (2025)APLLTD (2025)
Cash & Equivalents i2.63B834.80M
Total Current Assets i8.01B40.88B
Total Current Assets % of Revenue i43.9%62.5%
Total Current Liabilities i4.91B24.12B
Total Current Liabilities % of Revenue i26.9%36.9%
Long-Term Debt i137.00M467.70M
Long-Term Debt % of Revenue i0.8%0.7%
Total Shareholders Equity i7.49B51.90B
Retained Earnings i3.32B43.94B
Retained Earnings % of Revenue i18.2%67.2%
Property, Plant & Equipment i3.03B4.45B

Cash Flow Statement Comparison

MetricSANOFI (2025)APLLTD (2025)
Operating Cash Flow i7.22B-3.10B
Operating Cash Flow % of Revenue i39.6%-4.7%
Capital Expenditures i-253.00M-5.54B
Free Cash Flow i4.13B-4.76B
FCF Margin i22.6%-7.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSANOFIAPLLTD
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i23.03M196.56M
Float Shares i9.07M57.90M
% Held by Insiders i60.61%70.56%
% Held by Institutions i24.40%16.81%
% Held by Public i14.99%12.63%

Dividend Analysis & Yield Comparison: Sanofi India Limited vs Alembic Pharmaceuticals Ltd.

MetricSANOFIAPLLTD
Last 12-Month Dividend i₹192.00₹11.00
Last 12-Month Dividend Yield i4.60%1.09%
3-Year Avg Annual Dividend i₹245.33₹13.33
3-Year Avg Dividend Yield i2.49%1.17%
3-Year Total Dividends i₹736.00₹40.00
Ex-Dividend DateNov 07, 2025Jul 29, 2025